Variant report
Variant | esv13378 |
---|---|
Chromosome Location | chr6:63219158-63225196 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146590311 | chr6:63220215-63220216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563615827 | chr6:63220262-63220263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376357810 | chr6:63220298-63220299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575576704 | chr6:63220300-63220301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546069117 | chr6:63220307-63220308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530866786 | chr6:63220314-63220315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564708760 | chr6:63220351-63220352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188648847 | chr6:63220391-63220392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544497654 | chr6:63220608-63220609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551241234 | chr6:63220620-63220621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189061340 | chr6:63220668-63220669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139750884 | chr6:63220787-63220788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553414989 | chr6:63220864-63220865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568241845 | chr6:63220902-63220903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4710355 | chr6:63220914-63220915 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs34901541 | chr6:63221090-63221091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4710231 | chr6:63221113-63221114 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs191917063 | chr6:63221139-63221140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113984991 | chr6:63221148-63221149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560194206 | chr6:63221179-63221180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189568918 | chr6:63221192-63221193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs180757193 | chr6:63221207-63221208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149728142 | chr6:63221233-63221234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540500459 | chr6:63221248-63221249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145573192 | chr6:63221262-63221263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529041100 | chr6:63221345-63221346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546651815 | chr6:63221417-63221418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12206616 | chr6:63221430-63221431 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs562471349 | chr6:63221461-63221462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533050700 | chr6:63221478-63221479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76116017 | chr6:63221555-63221556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199616699 | chr6:63221564-63221565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150570294 | chr6:63221565-63221566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73494761 | chr6:63221584-63221585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs187460699 | chr6:63221639-63221640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190215746 | chr6:63221644-63221645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148868990 | chr6:63221669-63221670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568203575 | chr6:63221703-63221704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145297857 | chr6:63221711-63221712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147631002 | chr6:63221716-63221717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142001666 | chr6:63221728-63221729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116392739 | chr6:63221843-63221844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201041706 | chr6:63221885-63221886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78927897 | chr6:63221886-63221887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141151447 | chr6:63221887-63221888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs66476155 | chr6:63221888-63221889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9351875 | chr6:63221921-63221922 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs9341355 | chr6:63221945-63221946 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs375871582 | chr6:63221958-63221959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74749349 | chr6:63222012-63222013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Schizophrenia | 23813976 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:63220200-63220400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr6:63220600-63225000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr6:63222800-63223200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:63223200-63224400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:63224400-63224800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:63224600-63224800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr6:63224600-63225000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:63224600-63226400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr6:63224800-63225800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:63224800-63225800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
11 | chr6:63225000-63225400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr6:63225000-63226000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |